Aprea Therapeutics | ARS: Annual Report to Security Holders
Apr 25 19:35
Aprea Therapeutics | DEFA14A: Others
Apr 25 19:20
Aprea Therapeutics | DEF 14A: Definitive information statements
Apr 25 19:05
Aprea Therapeutics | 8-K: Current report
Apr 11 04:19
Aprea Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Apr 4 04:11
Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hamill John P.
Mar 29 06:00
Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Gilad Oren
Mar 29 06:00
Aprea Therapeutics | 8-K: Aprea Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update
Mar 26 20:19
Aprea Therapeutics | 10-K: Annual report
Mar 26 19:49
Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hamill John P.
Mar 15 08:55
Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Seizinger Bernd R.
Mar 15 08:55
Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director HENNEMAN JOHN B III
Mar 15 08:55
Aprea Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Gilad Oren
Mar 15 08:55
Aprea Therapeutics | 8-K: Current report
Mar 13 04:35
Aprea Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Sio Capital Management, LLC(7.49%)
Feb 14 21:04
Aprea Therapeutics | 424B3: Prospectus
Feb 10 01:08
Aprea Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-AIGH Capital Management, LLC(9.4%),Orin H(9.4%)
Feb 8 07:57
Aprea Therapeutics | 8-K: Current report
Feb 7 06:03
Aprea Therapeutics | 424B3: Prospectus
Feb 6 01:10
Aprea Therapeutics | EFFECT: Others
Feb 5 19:07
No Data
No Data